Droxidopa Copay Assistance

ቤት / Droxidopa Copay Assistance

አሁን የገንዘብ እፎይታ ያግኙ

Apply for Droxidopa Copay Assistance

የነጻ አገልግሎት ከከፍተኛ የቅጅ ክፍያ እርዳታ ፕሮግራሞች ጋር ያዛምዳል
በማመልከቻው ሂደት ውስጥ ስፔሻሊስቶች ይረዱዎታል
በእርስዎ የገንዘብ ድጋፍ ሁኔታ ላይ ራስ-ሰር ዝማኔዎችን ያግኙ
እስካሁን ከ$55 ሚሊዮን በላይ ለታካሚዎቻችን ዋስትና ተሰጥቷል።

ከአንድ ስፔሻሊስት ጋር ይነጋገሩ

እርዳታ እንዴት እንደሚሰራ

የታካሚያችንን ልዩ መድሃኒት ቤት ልምድ በማይዛመድ የሙሉ አገልግሎት ምቾት ማቀላጠፍ

1. የሽፋን/የጥቅማ ጥቅሞች ማረጋገጫዎን ያረጋግጡ

የእኛ የባለሙያዎች የሂሳብ አከፋፋዮች ቡድን ከኪስ ወጪዎች የሚቀንሱትን ምርጥ የሽፋን መንገዶችን ያገኛል።
2. ማዘዣን ወደ AmeriPharma® ያስተላልፉ

ከቀድሞው ፋርማሲዎ ወይም ከሐኪምዎ ጋር በመስራት ማዘዙን እናሰራለን፣ ይህም ሽግግሩን ፈጣን እና ቀላል ያደርገዋል።
3. የቅድሚያ ፍቃድ

የእኛ የስፔሻሊስቶች ቡድን ከ24 እስከ 72 ሰአታት ውስጥ ከኢንሹራንስ ኩባንያዎችዎ ፈቃድ ያገኛል።
4. የቅጅ ክፍያ እርዳታ እና የገንዘብ እርዳታ

የገንዘብ ዕርዳታን እናስከብራለን እና የጋራ ክፍያን፣ ከኪስ ውጪ ወጪዎችን እና ከፍተኛ ተቀናሾችን እንቀንሳለን። እስካሁን፣ AmeriPharma® ስፔሻላይቲ ኬር $55 ሚሊዮን ለታካሚዎቻችን የገንዘብ ድጋፍ አግኝቷል።
5. የነርሲንግ እንክብካቤ ማስተባበሪያ

AmeriPharma® በቤት ውስጥ ለሚደረጉ መርፌዎች ከኛ ልዩ ነርሶች ውስጥ አንዱን ሲያቀናጅ እና ሲያስተባብር የእርስዎን የጊዜ ሰሌዳ እና የቤት አካባቢ ያስቀድማል።
6. የመላኪያ ማስተባበር

መድሃኒቶች ሁልጊዜ የሚቀርቡት ለማጓጓዣ ልዩ መስፈርቶች በጥብቅ በማክበር ነው. በሚቀጥለው ቀን እና በሌሊት የቀዝቃዛ ሰንሰለት ማቅረቢያዎች በጊዜ ሰሌዳዎ ዙሪያ የተቀናጁ ናቸው።

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg

What Is Droxidopa?

Droxidopa is a generic form of the brand-name drug called Northera. This prescription medication was first approved by the FDA in 2014 for treating the symptoms of neurogenic orthostatic hypotension (NOH), which involves fainting, dizziness, or lightheadedness when standing after sitting or lying down. Droxidopa is a type of prodrug (a drug that is converted into an active form once it reaches its target area) and belongs to the class of alpha and beta-adrenergic agonists.

This medication is indicated to regulate standing blood pressure by temporarily increasing the level of norepinephrine in your body. Norepinephrine, also known as noradrenaline, is a type of neurotransmitter (brain chemical) that is needed to regulate blood pressure.

Droxidopa is available in oral capsule form and can only be obtained via a doctor’s prescription.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

What Is Droxidopa Used To Treat?

Droxidopa is used to treat symptomatic neurogenic orthostatic hypotension – a chronic and potentially debilitating condition characterized by a sustained drop of blood pressure upon standing due to low production or release of norepinephrine. This condition may arise as a result of autonomic failure and mainly occurs in patients suffering from certain neurologic disorders such as pure autonomic failure (PAF), multiple system atrophy (MSA), and Parkinson’s disease (PD).

These neurologic disorders mainly affect the patient’s autonomic nervous system (typically involved in regulating various involuntary functions such as heart rate, breathing, and blood pressure), which leads to inadequate release of norepinephrine. The dysregulation in norepinephrine release results in low blood pressure in neurogenic OH patients whenever they stand.

Due to a drop in blood pressure, neurogenic OH patients experience severe dizziness, lightheadedness, syncope, blurred vision, faintness (feeling of passing out), and loss of consciousness.

Between 80,000 – 150,000 people are thought to suffer from the symptoms of neurogenic OH in the United States.

የቅጅ ክፍያ እና የገንዘብ ድጋፍ

AmeriPharma™ ልዩ ፋርማሲ ለታካሚዎች እና ለቤተሰቦቻቸው የገንዘብ ሸክሞችን ያቃልላል

የላቀ ሶፍትዌር እርስዎን ከከፍተኛ-ዶላር ፋውንዴሽን ፕሮግራሞች ጋር ለማዛመድ የገንዘብ ምንጮችን ያገኛል
የእኛ የጋራ ክፍያ እርዳታ ስፔሻሊስቶች በማመልከቻው ሂደት ላይ ያግዛሉ።
በገንዘቡ ሁኔታ ላይ አውቶማቲክ ማሻሻያ ለእርስዎ እና ለሐኪምዎ ይላካል

https://ameripharmaspecialty.com/wp-content/uploads/2024/05/doctor-patient.jpg

Droxidopa Dosage

The recommended initial (starting) dose of droxidopa is 100 mg 3 times a day during waking hours (in the morning, at midday, and in the late afternoon at least 3 hours before bedtime). The dose of droxidopa is titrated (adjusted) according to symptomatic response (where the patient’s symptoms respond to the drug).

Depending on the symptomatic response, the droxidopa dose can be increased by increments of 100 mg 3 times a day, up to a maximum dose of 600 mg three times/day. The maximum recommended total daily dose of droxidopa is 1800 mg. Dose titration and adjustment must be done by the treating doctor.

The dose of droxidopa could vary from patient to patient and is done in a very stringent fashion to improve neurogenic OH symptoms and avoid an excessive increase in blood pressure.

What To Do if You Miss a Dose

Take your dose consistently as prescribed by your doctor. In case of a missed dose, avoid taking a double dose of droxidopa to compensate for the missed dose.

If you accidentally took your dose less than 3 hours before bedtime, consult your healthcare provider immediately to reduce the risk of supine hypertension.

Droxidopa Side Effects

Some common side effects reported by patients taking droxidopa include but are not limited to:

ማቅለሽለሽ
መፍዘዝ
ራስ ምታት
Hypertension (increased blood pressure)

These symptoms are temporary and can be managed easily. However, if the symptoms persist and do not go away within two weeks during droxidopa therapy, you should report to your healthcare provider immediately.

Moreover, some side effects can be severe and require immediate medical attention, such as:

Supine Hypertension
Droxidopa can cause or worsen supine hypertension in NOH patients. Supine hypertension is a condition in which a patient’s blood pressure rises when they lie flat on their back. Supine hypertension increases the risk of stroke if not appropriately managed.

Doctors recommend that patients should check their blood pressure before going to bed, and while resting or sleeping, they should elevate the head of the bed to avoid the risk of supine hypertension. Blood pressure should also be monitored whenever changing the Droxidopa dose.

Arrhythmias, Congestive Heart Failure, and Ischemic Heart Disease
Droxidopa therapy may exacerbate existing arrhythmias, congestive heart failure, and ischemic heart disease. It is recommended to discuss your health status with your doctor before initiating droxidopa.

Severe Allergic Reaction
Droxidopa contains tartrazine (a lemon yellow azo dye used in food coloring and medication), which may cause a severe allergic reaction (including bronchial asthma) in some patients with NOH.

Hyperpyrexia and Confusion
Hyperpyrexia (a condition where the body temperature goes above 106.7 degrees Fahrenheit) and confusion symptoms are also reported in patients receiving droxidopa therapy during post-marketing surveillance.

Therefore, carefully observing the patients when the droxidopa dosage is changed is recommended.